tiprankstipranks
Advertisement
Advertisement

NTLA Stock Latest News

Cathie Wood’s ARK Investment buys 169K shares of Intellia Therapeutics today
The FlyCathie Wood’s ARK Investment buys 169K shares of Intellia Therapeutics today
2d ago
NTLA
Intellia Therapeutics Earnings Call Highlights Clinical Momentum
PremiumCompany Announcements
Intellia Therapeutics Earnings Call Highlights Clinical Momentum
5d ago
NTLA
Intellia Therapeutics: Buy Rating Reiterated as Clinical Progress and Risk Management Support Unchanged $29 Price Target
PremiumRatings
Intellia Therapeutics: Buy Rating Reiterated as Clinical Progress and Risk Management Support Unchanged $29 Price Target
12d ago
NTLA
Intellia, Roku Trend with Analysts: What Investors Should Know
PremiumWeekend Updates
Intellia, Roku Trend with Analysts: What Investors Should Know
18d ago
NTLA
ROKU
Analyst Maintains Buy on Intellia as Lonvo-z Progress and Strong Cash Runway Support Unchanged $49 Price Target
PremiumRatings
Analyst Maintains Buy on Intellia as Lonvo-z Progress and Strong Cash Runway Support Unchanged $49 Price Target
19d ago
NTLA
Intellia Therapeutics upgraded to Outperform from In Line at Evercore ISI
PremiumThe FlyIntellia Therapeutics upgraded to Outperform from In Line at Evercore ISI
19d ago
NTLA
Intellia Therapeutics upgraded to Outperform from In Line at Evercore ISI
Premium
The Fly
Intellia Therapeutics upgraded to Outperform from In Line at Evercore ISI
19d ago
NTLA
Intellia Therapeutics reports Q2 EPS (80c), consensus (78c)
Premium
The Fly
Intellia Therapeutics reports Q2 EPS (80c), consensus (78c)
20d ago
NTLA
Fuelcell, Fastly, HPE, Intellia, Alcoa Insider Shock
PremiumWeekend Updates
Fuelcell, Fastly, HPE, Intellia, Alcoa Insider Shock
1M ago
AA
HPE
SanDisk, Vertiv, Intellia, Rocket, AeroVironment Trending With Analysts
PremiumWeekend Updates
SanDisk, Vertiv, Intellia, Rocket, AeroVironment Trending With Analysts
1M ago
RKT
VRT
Intellia Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
PremiumThe Fly
Intellia Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
1M ago
NTLA
BlackBerry, Sony, Sunrun, Credo, Intellia: Insider Sell-Off Shock
PremiumWeekend Updates
BlackBerry, Sony, Sunrun, Credo, Intellia: Insider Sell-Off Shock
2M ago
BB
RUN
Intellia Therapeutics price target raised to $17 from $12 at Wedbush
PremiumThe FlyIntellia Therapeutics price target raised to $17 from $12 at Wedbush
2M ago
AZN
ALNY
Intellia Therapeutics rises 12.9%
Premium
The Fly
Intellia Therapeutics rises 12.9%
2M ago
NTLA
Intellia Therapeutics rises 10.7%
Premium
The Fly
Intellia Therapeutics rises 10.7%
2M ago
NTLA
Midday Fly By: Fox to acquire Roku, Salesforce to buy Fin
PremiumThe Fly
Midday Fly By: Fox to acquire Roku, Salesforce to buy Fin
2M ago
AA
ACN
Sell Rating Maintained on Clinical and Commercial Uncertainty; $9 Price Target Reaffirmed
PremiumRatings
Sell Rating Maintained on Clinical and Commercial Uncertainty; $9 Price Target Reaffirmed
2M ago
NTLA
Intellia Highlights Strong Phase 3 Lonvo-z HAE Results
PremiumCompany Announcements
Intellia Highlights Strong Phase 3 Lonvo-z HAE Results
2M ago
8K
NTLA
Intellia: Phase 3 HAELO Success Underpins Buy Rating as Analyst Maintains $25 Price Target
PremiumRatings
Intellia: Phase 3 HAELO Success Underpins Buy Rating as Analyst Maintains $25 Price Target
2M ago
NTLA
Intellia Therapeutics presents additional results from Phase 3 HAELO trial
PremiumThe FlyIntellia Therapeutics presents additional results from Phase 3 HAELO trial
2M ago
NTLA
Intellia Shareholders Back Board, Executive Pay and Auditor
Premium
Company Announcements
Intellia Shareholders Back Board, Executive Pay and Auditor
3M ago
8K
NTLA
Intellia Therapeutics: Buy Rating Reiterated on De-Risked HAE and ATTR Pipelines; $29 DCF-Based Price Target Maintained
Premium
Ratings
Intellia Therapeutics: Buy Rating Reiterated on De-Risked HAE and ATTR Pipelines; $29 DCF-Based Price Target Maintained
3M ago
NTLA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >